Copyright
©The Author(s) 2022.
World J Gastrointest Oncol. Aug 15, 2022; 14(8): 1574-1584
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1574
Published online Aug 15, 2022. doi: 10.4251/wjgo.v14.i8.1574
Figure 4 Diagnostic value evaluation of RASSF1A methylation rate in plasma for discriminating T1-T4 stage hepatocellular carcinoma and liver cirrhosis.
A: T1 stage hepatocellular carcinoma (HCC) and liver cirrhosis (LC); B: T2 stage HCC and LC; C: T3 stage HCC and LC; D: T4 stage HCC and LC.
- Citation: Li J, Li H, Run ZC, Wang ZL, Jiang T, An Y, Li Z. RASSF1A methylation as a biomarker for detection of colorectal cancer and hepatocellular carcinoma. World J Gastrointest Oncol 2022; 14(8): 1574-1584
- URL: https://www.wjgnet.com/1948-5204/full/v14/i8/1574.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v14.i8.1574